• ¿Documento equivocado? Cámbialo gratis
  • Escrito por estudiantes que aprobaron
  • Inmediatamente disponible después del pago
  • Leer en línea o como PDF
Vender
¿Dónde estudias?
Tu idioma
Document preview thumbnail
Vista previa 4 fuera de 98 páginas
Examen

Drug Information Specialist Certification Exam 2026: Comprehensive Professional Practice Test — Drug Information Resources, Literature Evaluation, Adverse Drug Reactions, Medication Safety, Regulatory Affairs & Pharmacoeconomics — 190 Multiple-Choice

Document preview thumbnail
Vista previa 4 fuera de 98 páginas

Drug Information Specialist Certification Exam 2026: Comprehensive Professional Practice Test — Drug Information Resources, Literature Evaluation, Adverse Drug Reactions, Medication Safety, Regulatory Affairs & Pharmacoeconomics — 190 Multiple-Choice Questions with Answers & Detailed Rationales

Vista previa del contenido

Drug Information Specialist Certification Exam 2026:
Comprehensive Professional Practice Test — Drug Information
Resources, Literature Evaluation, Adverse Drug Reactions,
Medication Safety, Regulatory Affairs & Pharmacoeconomics — 190
Multiple-Choice Questions with Answers & Detailed Rationales




SECTION 1: DRUG INFORMATION RESOURCES AND LITERATURE EVALUATION (Questions 1-
38)

Question 1



A drug information specialist receives a call from a physician asking about the mechanism of
action of a newly approved monoclonal antibody. Which type of tertiary resource would
provide the most comprehensive and current information?



A. Package insert

B. Systematic review

C. Drug Facts and Comparisons

D. Primary literature article



Correct Answer: C



Explanation: Drug Facts and Comparisons is a tertiary resource that compiles comprehensive
drug monographs including mechanism of action for approved medications.



Question 2

,When evaluating a clinical trial for potential bias, a drug information specialist notices that
neither the participants nor the investigators knew which treatment group participants were
assigned to. This study design element is best described as:



A. Single blinding

B. Double blinding

C. Open-label design

D. Crossover design



Correct Answer: B



Explanation: Double blinding means both participants and investigators are unaware of
treatment assignments, reducing detection and performance bias.



Question 3



A pharmacist needs to determine the bioequivalence of a generic formulation compared to
its brand-name counterpart. Which parameter is most critical to evaluate?



A. Dissolution rate

B. Maximum plasma concentration (Cmax)

C. Area under the curve (AUC)

D. Time to maximum concentration (Tmax)



Correct Answer: C



Explanation: AUC represents total drug exposure and is the primary pharmacokinetic
parameter for establishing bioequivalence between formulations.

,Question 4



Which of the following best describes the purpose of a meta-analysis in drug information
practice?



A. To generate new primary data from clinical trials

B. To systematically combine results from multiple studies to derive pooled estimates

C. To provide expert opinion on controversial therapeutic issues

D. To describe individual patient case outcomes



Correct Answer: B



Explanation: Meta-analysis statistically combines results from multiple studies, increasing
statistical power and providing pooled effect estimates.



Question 5



A drug information specialist is asked to evaluate a study examining the association between
a rare adverse event and a newly marketed medication. Which study design would be most
appropriate for investigating this relationship?



A. Randomized controlled trial

B. Case-control study

C. Cross-sectional study

D. Phase I clinical trial



Correct Answer: B

, Explanation: Case-control studies are efficient for studying rare outcomes by retrospectively
comparing affected cases with unaffected controls.



Question 6



When assessing the internal validity of a randomized controlled trial, which factor is most
important to evaluate?



A. Sample size calculation

B. Randomization and allocation concealment methods

C. Geographic location of study sites

D. Number of authors on the publication



Correct Answer: B



Explanation: Proper randomization and allocation concealment prevent selection bias and
are fundamental to internal validity in RCTs.



Question 7



A drug information specialist receives a question about the off-label use of a medication.
Which resource would be most appropriate to consult first?



A. FDA-approved package insert

B. Micromedex

C. The Cochrane Library

D. United States Pharmacopeia



Correct Answer: B

Información del documento

Subido en
19 de octubre de 2026
Número de páginas
98
Escrito en
2026/2027
Tipo
Examen
Contiene
Preguntas y respuestas
$25.49

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Vendido
0
Seguidores
0
Artículos
305
Última venta
-




Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes